Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.3 - [PFIZER INC]

30 Oct 2015 14:12

RNS Number : 0663E
T.Rowe Price Associates
30 October 2015
Β 

FORM 8.3

IRISH TAKEOVER PANEL

Β 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

Β 

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES

REPRESENTING 1% OR MORE

Β 

1. KEY INFORMATION

Β 

Name of person dealing (Note 1)

T. ROWE PRICE ASSOCIATES, INC.

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ISIN: US7170811035

Date of dealing

29 October 2015

Β 

Β 

Β 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

Β 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Β 

Β 

Β 

Long

Short

Β 

Β 

Number (%)

Number (%)

(1) Relevant securities

Β 

101,403,958 1.64%

(2) Derivatives (other than options)

Β 

(3) Options and agreements to purchase/sell

Β 

Total

Β 

101,403,958 1.64%

Β 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Β 

Class of relevant security:

Β 

Long

Short

Β 

Β 

Number (%)

Number (%)

(1) Relevant securities

Β 

(2) Derivatives (other than options)

Β 

(3) Options and agreements to purchase/sell

Β 

Total

Β 

Β 

Β 

3. DEALINGS (Note 4)

Β 

(a) Purchases and sales

Β 

Purchase/sale

Β 

Number of securities

Price per unit (Note 5)

Purchases

Β 

Β 

Β 

Β 

Β 

Sales

15,700

25,000

302,000

475,200

650,000

5,000

38

200,600

110

1,000

34.425 USD

34.465 USD

34.637 USD

34.848 USD

35.322 USD

35.375 USD

34.510 USD

34.770 USD

34.811 USD

34.830 USD

Β 

Β 

(b) Derivatives transactions (other than options)

Β 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Β 

Product name,

e.g. call option

Β 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)

Β 

Β 

(ii) Exercising

Β 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

Β 

Β 

(d) Other dealings (including new securities) (Note 4)

Β 

Nature of transaction (Note 8)

Β 

Details

Price per unit (if applicable) (Note 5)

Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Β 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

None

Β 

Β 

Β 

Is a Supplemental Form 8 attached? (Note 9) NO

Β 

Β 

Date of disclosure

30 October 2015

Contact name

Gary Greb

Telephone number

001 410 345 2527

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEURASRVRAROAA
Date   Source Headline
7th May 201411:20 amBUSForm 8.3 - Pfizer Inc
7th May 201410:40 amRNSForm 8.5 (EPT/RI) astrazeneca PLC
7th May 201410:38 amRNSForm 8.5 (EPT/RI) Astrazeneca PLC
7th May 201410:36 amRNSForm 8.5 (EPT/RI) Pfizer INC
7th May 201410:31 amRNSRule 2.10 Announcement
7th May 201410:30 amRNSForm 8.5 (EPT/RI) Astrazeneca PLC
7th May 201410:29 amRNSForm 8.5 (EPT/RI) Pfizer Inc
7th May 20147:00 amRNSBENEFITS OF A COMBINATION WITH ASTRAZENECA
7th May 20147:00 amRNSForm 8.5 (EPT/NON-RI)
6th May 20146:16 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
6th May 20146:08 pmRNSForm 8.5 (EPT/NON-RI)(OPD)
6th May 20145:15 pmRNSForm 8 (DD) - Pfizer Inc.
6th May 20144:46 pmRNSForm 8.3 - Pfizer Inc
6th May 20144:42 pmRNSForm 8.3 - Pfizer Inc
6th May 20144:16 pmRNSForm 8.5 (EPT/RI)replacement - Pfizer Inc
6th May 20144:14 pmRNSForm 8.5 (EPT/RI) Replacement - Pfizer Inc
6th May 20144:11 pmRNSForm 8.5 (EPT/RI)Replacement - Pfizer Inc
6th May 20144:07 pmRNSForm 8.5 (EPT/RI)Replacement - Pfizer Inc
6th May 20144:05 pmRNSForm 8.5 (EPT/RI) Replacement - Pfizer Inc
6th May 20144:04 pmRNSForm 8.5 (EPT/RI)replacement - Pfizer Inc
6th May 20144:02 pmBUSForm 8.3 - PFIZER INC
6th May 20143:56 pmRNSForm 8.5 (EPT/RI)Replacement - Astrazeneca PLC
6th May 20143:53 pmRNSForm 8.5 (EPT/RI) Replacement - Astrazeneca PLC
6th May 20143:51 pmRNSForm 8.5 (EPT/RI)Replacement - Astrazeneca PLC
6th May 20143:51 pmRNSForm 8.5 (EPT/RI)Replacement - Astrazeneca PLC
6th May 20143:49 pmRNSForm 8.5 (EPT/RI) Replacement - Astrazeneca PLC
6th May 20143:46 pmRNSForm 8.5 (EPT/RI)replacement - Astrazeneca PLC
6th May 20143:34 pmRNSForm 8.3 - Pfizer Inc
6th May 20143:23 pmRNSForm 8.3 - Pfizer Inc
6th May 20143:19 pmRNSForm 8.3 - Pfizer Inc
6th May 20143:19 pmRNSForm 8.3 - Pfizer Inc
6th May 20143:18 pmRNSForm 8.3 - astrazeneca plc
6th May 20143:16 pmRNSForm 8.3 - PFIZER INC
6th May 20143:15 pmRNSForm 8.3 - AstraZeneca Plc
6th May 20143:14 pmBUSForm 8.3 - Pfizer Inc.
6th May 20143:00 pmRNSForm 8.3 - Pfizer Inc.
6th May 20142:51 pmRNSForm 8.3 - [PFIZER INC]
6th May 20142:48 pmBUSForm 8.3 - Pfizer Inc
6th May 20142:31 pmRNSForm 8.3 - [Pfizer/Astrazeneca]
6th May 20141:54 pmRNSForm 8.3 - Pfizer Inc
6th May 20141:48 pmRNSForm 8.3 - AstraZeneca Plc
6th May 20141:28 pmRNSForm 8.3 - Pfizer Inc
6th May 20141:25 pmRNSForm 8.3 - AstraZeneca Plc
6th May 20141:20 pmRNSForm 8.3 - [AstraZeneca Plc]
6th May 20141:14 pmBUSForm 8.3 - Pfizer Inc.
6th May 20141:13 pmRNSForm 8.5 (EPT/RI)
6th May 20141:09 pmRNSForm 8.5 (EPT/NON-RI)
6th May 20141:07 pmBUSForm 8.3 - Pfizer Inc.
6th May 20141:06 pmRNSForm 8.5 (EPT/RI)
6th May 201412:35 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.